Daily Edition · Page 1

THE DAILY INDEX

Technology, AI, software, security, crypto and business

Across today’s newsletters

Today’s Index

MAJOR EUROPEAN HEALTHCARE NETWORK DISCLOSES SECURITY BREACH

AMEOS Group, an operator of a Central European healthcare network, suffered a security breach that may have exposed customer, employee, and partner information. In response to the breach, AMEOS has shut down all IT systems and terminated all external and internal network connections while it responds to the incident. AMEOS has stated that it doesn't currently have evidence of any data being leaked, but it is continuing to investigate.

SOLANA & JITO EXECS NAMED IN EXPANDED RICO SUIT OVER PUMP.FUN

Burwick Law and Wolf Popper have amended their RICO lawsuit against Pump.fun to include the Solana Foundation, Solana Labs, Jito Labs, and multiple executives, including Anatoly Yakovenko and Raj Gokal, accusing them of facilitating an illegal digital gambling and money transmission enterprise. The complaint alleges violations of AML laws, the Bank Secrecy Act, and claims Pump enabled the laundering of stolen Bybit funds by the Lazarus Group. Plaintiffs claim Pump has generated $723 million from a system they liken to a “digital slot machine,” while Jito is accused of frontrunning winning trades via MEV.

SPACEX'S CELLULAR STARLINK LAUNCHES TODAY VIA T-MOBILE: WHAT YOU NEED TO KNOW

T-Mobile and SpaceX's T-Satellite service is now available to subscribers, allowing smartphone users to remain connected even in deadzones. Existing T-Mobile customers can purchase the cellular Starlink service as an add-on - those on pricier plans like Experience Beyond and Go5G Next get it as a free perk. People on other networks can also subscribe through a secondary eSIM. Those who participated in the free trial should now expect to be charged for the service.

NEURALINK SEES $1 BILLION OF REVENUE BY 2031 IN VAST EXPANSION

Neuralink expects to put its chips in 20,000 people a year and generate at least $1 billion in annual revenue by 2031. It plans to have about five large clinics in operation and at least three versions of its device available. The company's figures assume a conservative reimbursement of $50,000 per surgery. Several other brain companies are building and testing similar devices. No brain-computer interfaces have yet been commercially approved for permanent implantation by the US FDA - Neuralink expects to gain regulatory approval in the US for its first device by 2029.

TLDR IndexPage 1